Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Y-4 Tablets Compared With Pregabalin and Riluzole in Healthy Participants
NCT07618715Phase 1Not yet recruiting
- Sponsor
- NeuroDawn
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of Y-4 (3 arms), sponsored by NeuroDawn. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Curve from Time Zero to Last Quantifiable Concentration and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Y-4
Beyond the preview
Go deeper on NCT07618715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618715.